Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-11-063209

← back to feed
Filed
Nov 14, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 9, 2011 21.37M sh
Capex Q3 2011 · Sep 30, 2011 $2.86K
Capex Q3 2011 · Sep 30, 2010 $0
Stockholders Equity Q3 2011 · Sep 30, 2011 $286.73K
Stockholders Equity Q3 2011 · Dec 31, 2010 $1.66M
Current Liabilities Q3 2011 · Sep 30, 2011 $2.21M
Current Liabilities Q3 2011 · Dec 31, 2010 $1.89M
Current Assets Q3 2011 · Sep 30, 2011 $2.49M
Current Assets Q3 2011 · Dec 31, 2010 $3.53M
Total Assets Q3 2011 · Sep 30, 2011 $2.5M
Total Assets Q3 2011 · Dec 31, 2010 $3.55M
Net Income Q3 2011 · Sep 30, 2011 −$278.2K
Net Income Q3 2011 · Sep 30, 2011 −$1.6M
Net Income Q3 2011 · Sep 30, 2010 −$687.24K
Net Income Q3 2011 · Sep 30, 2010 −$1.66M
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$352.29K
Cash And Equivalents Q3 2011 · Sep 30, 2010 $154.3K
Cash And Equivalents Q3 2011 · Dec 31, 2009 $108.99K
Sga Expense Q3 2011 · Sep 30, 2010 $386.21K
Sga Expense Q3 2011 · Sep 30, 2010 $1.09M
Rd Expense Q3 2011 · Sep 30, 2010 $128.43K
Rd Expense Q3 2011 · Sep 30, 2010 $384.05K
Operating Income Q3 2011 · Sep 30, 2010 −$514.64K
Operating Income Q3 2011 · Sep 30, 2010 −$1.47M
Revenue Q3 2011 · Sep 30, 2010 $0
Revenue Q3 2011 · Sep 30, 2010 $0